OAYWX
Price
$26.12
Change
+$0.16 (+0.62%)
Updated
Dec 3 closing price
Net Assets
988.32M
PRIKX
Price
$17.67
Change
+$0.18 (+1.03%)
Updated
Dec 3 closing price
Net Assets
11.21B
Interact to see
Advertisement

OAYWX vs PRIKX

Header iconOAYWX vs PRIKX Comparison
Open Charts OAYWX vs PRIKXBanner chart's image
Oakmark Global Select Advisor
Price$26.12
Change+$0.16 (+0.62%)
VolumeN/A
Net Assets988.32M
T. Rowe Price Real Assets I
Price$17.67
Change+$0.18 (+1.03%)
VolumeN/A
Net Assets11.21B
OAYWX vs PRIKX Comparison Chart in %
View a ticker or compare two or three
VS
OAYWX vs. PRIKX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OAYWX is a StrongBuy and PRIKX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRIKX has more cash in the bank: 11.2B vs. OAYWX (988M). PRIKX pays higher dividends than OAYWX: PRIKX (1.52) vs OAYWX (1.15). OAYWX was incepted earlier than PRIKX: OAYWX (9 years) vs PRIKX (10 years). OAYWX (0.96) is less costly to investors than PRIKX (0.67). OAYWX is a more actively managed with annual turnover of: 44.00 vs. PRIKX (41.30). OAYWX has a lower initial minimum investment than PRIKX: OAYWX (100000) vs PRIKX (500000). PRIKX annual gain was more profitable for investors over the last year : 17.82 vs. OAYWX (15.65). PRIKX return over 5 years is better than : 55.03 vs. OAYWX (28.78).
OAYWXPRIKXOAYWX / PRIKX
Total Expense Ratio0.960.67143%
Annual Report Gross Expense Ratio0.960.67143%
Fund Existence9 years10 years-
Gain YTD18.19027.48966%
Front LoadN/AN/A-
Min. Initial Investment10000050000020%
Min. Initial Investment IRAN/AN/A-
Net Assets988M11.2B9%
Annual Yield % from dividends1.151.5276%
Returns for 1 year15.6517.8288%
Returns for 3 years44.2831.50141%
Returns for 5 years28.7855.0352%
Returns for 10 yearsN/A118.97-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CATX2.210.16
+7.80%
Perspective Therapeutics
PHIO1.290.06
+4.88%
Phio Pharmaceuticals Corp
NHI78.850.63
+0.81%
National Health Investors
VRSK224.48-0.37
-0.16%
Verisk Analytics
IVA4.14-0.04
-0.96%
Inventiva SA